Evidence-Based Benefits
- LDL cholesterol reduction — a 2012 meta-analysis by Ras et al. in PLoS ONE (124 studies) confirmed that 2.15g/day plant sterols reduced LDL-C by 8.8% on average, with dose-response benefits up to 3g/day.
- Additive statin benefit — Scholle et al. (2009) found that adding 2g/day plant sterols to statin therapy provided an additional 8-10% LDL reduction beyond statins alone, offering a meaningful clinical advantage.
- Cardiovascular risk modeling — based on LDL reductions, epidemiological models estimate plant sterol consumption reduces cardiovascular event risk by 12-20% over a lifetime, prompting FDA and EFSA health claims.
- Broad applicability — plant sterols are effective across diverse populations, including those with familial hypercholesterolemia, type 2 diabetes, and metabolic syndrome.